A&M NACR or PEPI Better Long Term

Hey all, quick question.

At a UMM PC firm and got offers via headhunters for both A&M's RX (restructuring) and PEPI groups. Want an idea of what sets me up better long term, as in what option is better regardless of whether I decide to stay long term or decide to exit into IB or buyside. I know I'm kinda asking for the best of it all, but wanted to see if anyone on here has any thoughts about these two groups.

12 Comments
 

Based on the most helpful WSO content, here's what you need to know:

  1. A&M Restructuring (RX):

    • A&M is widely recognized as a top-tier firm for restructuring and turnaround work. This group is considered "best-in-class" in this area, where even MBB doesn't compete much.
    • Long-term, RX provides strong financial and operational skills, which are highly transferable to senior executive roles or midcap PE firms.
    • If you're considering exits into investment banking (IB), RX experience is highly valued, especially for distressed M&A or special situations groups.
  2. A&M Private Equity Performance Improvement (PEPI):

    • PEPI focuses on operational improvements for private equity portfolio companies, which can give you exposure to both financial and operational aspects of businesses.
    • This group is strong for private equity-related work and can position you well for exits into midcap PE firms or operational roles within portfolio companies.
    • PEPI is particularly beneficial if you're interested in staying close to private equity or transitioning into operational leadership roles.

Key Considerations:

  • Long-term Career Goals:
    If you're leaning toward IB or distressed investing, RX might be the better choice due to its strong reputation in restructuring and distressed M&A.
    If you're more interested in private equity or operational roles, PEPI could be a better fit.

  • Skill Development:
    RX will develop your financial restructuring and turnaround expertise, while PEPI will enhance your operational and performance improvement skills.

Both groups are solid options, but your decision should align with your long-term goals and the type of work you enjoy most.

Sources: How is A&M perceived in the industry?, Best PE Analyst Programs vs Opportunity Cost (top IB), Best schools for Texas IB/PE, Bain Capital PE vs PJT RSSG, Breaking into REPE/development from appraisal

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

PEPI is going to set you up for OPS work at PE funds. A&M NACR is going to set you up for RX IB, certain credit funds, certain distressed focused PE funds. Both can send people to Corporate Finance roles. 

Long term NACR is better IMO. A&M NACR Comp model is very solid, and though PEPI follows a similar model, they don't get the same flow per head that NACR gets. 

 

Gotcha, is the restructuring work interesting long term though? Have seen a lot of posts on here saying RX work is mind numbing, which concerns me a little bit when considering a long term career. Or is that applicable to RX IB only?

 

Curious where you saw that as I feel wso actually goes the other direction and overblows the intellectual stimulation/big brain work needed in rx. I think it is more interesting than doing PEPI long term though.

What level would you be coming in as?

 

Nope, investing role. I did have some limited work exp at a different company in operational roles but that was primarily internships. 

 

Amet labore voluptatem a officia et qui. Deserunt pariatur ullam officiis rerum voluptatem. Totam ut aut et eum maiores.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”